Alzheimer's disease: Case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 144, Issue 7, 2007, Pages 895-899

  Piccardi, Mariapaola ^a   Congiu, Donatella ^a   Squassina, Alessio ^a   Manconi, Francesca ^a   Putzu, Paolo Francesco ^b   Mereu, Rosa Maria ^b   Chillotti, Caterina ^a   Del Zompo, Maria ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Division of Geriatrics Local Health Agency 8   (Italy)

Author keywords

Candidate genes; Cholinergic system; Sardinian ethnicity

Indexed keywords

ACETYLCHOLINESTERASE; APOLIPOPROTEIN E; CHOLINE ACETYLTRANSFERASE; CHOLINESTERASE;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ACETYLCHOLINESTERASE; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; BUTYRYLCHOLINESTERASE; CASE-CONTROL STUDIES; CHOLINE O-ACETYLTRANSFERASE; CHOLINESTERASE REACTIVATORS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HUMANS; ITALY; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 35148854532     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30548     Document Type: Article

References (37)

1. Arcos-Burgos M, Muenke M. 2002. Genetics of populations isolates. Clin Genet 61:233-247.
2. Bertram L, Blacker D, Crystal A, Mullin K, Keeney D, Jones J, Basu S, Yhu S, Guenette S, McInnis M, Go R, Tanzi R. 2000. Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies. Exp Gerontol 35:1353-1361.
3. Bosco P, Guéant-Rodriguez RM, Anello G, Spada RS, Romanoc A, Caraci F, Ferri R, Guéant JL. 2005. Allele ε4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy. Neurosci Lett 388:168-172.
4. Brindle N, Song Y, Rogaeva E, Premkumar S, Levesque G, Yu G, Ikeda M, Nishimura M, Paterson A, Sorbi S, Duara R, Farrer L, St George-Hyslop P. 1998. Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease. Hum Mol Genet 7:933-935.
5. Cavalli-Sforza LL. 1997. Genes, peoples, and language. Proc Natl Acad Sci USA 94:7719-7724.
6. Cook LJ, Ho LW, Wang L, Terrenoire E, Brayne C, Evans JG, Xuereb J, Cairns NJ, Turic D, Hollingworth P, Moore PJ, Jehu L, Archer N, Walter S, Foy C, Edmondson A, Powell J, Lovestone S, Williams J, Rubinsztein DC. 2005. Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study. Am J Med Genet Part B 132B:5-8.
7. Corder E, Saunders A, Risch N, Strittmatter W, Schmechel D, Gaskell P, Rimmler J, Locke P, Conneally P, Schmader K, Small G, Roses A, Haines J, Pericak-Vance M. 1994. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 7:180-184.
8. Crawford F, Fallin D, Suo Z, Abdullah L, Gold M, Gauntlett A, Duara R, Mullan M. 1998. The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations. Neurosci Lett 249:115-118.
9. Folstein MF, Folstein SE, McHugh PR. 1975. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
10. Harold D, Peirce T, Moskvina V, Myers A, Jones S, Hollingworth P, Moore P, Lovestone S, Powell J, Foy C, Archer N, Walter S, Edmonson A, McIlroy S, Craig D, Passmore PA, Goate A, Hardy J, O'Donovan M, Williams J, Liddell M, Owen MJ, Jones L. 2003. Sequence variation in the ChAT locus shows no association with late-onset Alzheimer's disease. Hum Genet 113:258-267.
11. Hixson JE, Vernier DT. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548.
12. Jensen FS, Nielsen LR, Schwartz M. 1996. Detection of the plasma Cholinesterase K variant by PCR using an amplification-created restriction site. Hum Hered 46:26-31.
13. Kehoe PG, Williams H, Holmans P, Wilcock G, Cairns NJ, Neal J, Owen MJ. 1998. The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease. J Med Genet 35:1034-1035.
14. Ki CS, Na DL, Kim JW, Kim HJ, Kim DK, Yoon BK. 1999. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease. Am J Med Genet 88:113-115.
15. Lehmann DJ, Johnston C, Smith AD. 1997. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum Mol Genet 6:1933-1936.
16. Lehmann DJ, Williams J, McBroom J, Smith AD. 2001. Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups. Neuroscience 108:541-554.
17. McElroy SP, Crawford VL, Dylan KB, McClendon BM, Vahidassr MD, Lawson JT, Passmore AP. 2000. Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland. J Med Genet 37:182-185.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944.
19. Mubumbila V, Sutter A, Ptok U, Heun R, Quirin-Stricker C. 2002. Identification of a single nucleotide polymorphism in the choline acetyltransferase gene associated with Alzheimer's disease. Neurosc Letters 333:9-12.
20. Peltonen L, Palotie A, Lange K. 2000. Use of population isolates for mapping complex traits. Nat Rev Genet 1:182-190.
21. Piscopo P, Manfredi A, Malvezzi-Campeggi L, Crestini A, Spadoni O, Cherchi R, Deiana E, Piras MR, Confaloni A. 2006. Genetic study of Sardinian patients with Alzheimer's disease. Neurosci Lett 398:124-128.
22. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. 1993. Apolipoprotein E phenotype and Alzheimer's disease. Lancet 342:697-699.
23. Roses AD. 1996. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 47:387-400.
24. Rubinsztein DC, Easton DF. 1999. Apolipoprotein E genetic variation and Alzheimer's disease, a meta-analysis. Dement Geriatr Cogn Disord 10:199-209.
25. Russ C, Powell J, Lovestone S, Holmes C. 1998. K variant of butyrycholinesterase and late-onset Alzheimer's disease. Lancet 351:881.
26. Scacchi R, Gambina G, Ruggeri M, Martini MC, Ferrari G, Silvestri M, Schiavon M, Corbo RM. 1999. Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease. Neurosci Lett 259:33-36.
27. Schwarz S, Eisele T, Diehl J, Muller U, Forstl H, Kurz A, Riemenschneider M. 2003. Lack of association between a single nucleotide polymorphism within the choline acetyltransferase gene and patients with Alzheimer's disease. Neurosci Lett 343:167-170.
28. Sham PC, Curtis D. 1995. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
29. Singleton AB, Smith G, Gibson AM, Woodward R, Perry RH, Ince PG, Edwardson JA, Morris CM. 1998. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Hum Mol Genet 7:937-939.
30. Sorbi S, Nacmias B, Forleo P, Latorraca S, Gobbini I, Bracco R, Piacentini S, Amaducci L. 1994. APOE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett 177:100-102.
31. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981.
32. Talbot C, Lendon C, Craddock N, Shears S, Morris J, Goate A. 1994. Protection against Alzheimer's disease with apoE ε2. Lancet 343:1432-1433.
33. Tilley L, Morgan K, Grainger J, Marsters P, Morgan L, Lowe J, Xuereb J, Wischik C, Harrington C, Kalsheker N. 1999. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease. Eur J Hum Genet 7:659-663.
34. Wiebusch H, Poirier J, Sevigny P, Schappert K. 1999. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease. Hum Genet 104:158-163.
35. Wright AF, Carothers AD, Pirastu M. 1999. Population choice in mapping genes for complex diseases. Nature Genetic 23:397-404.
36. Zhao JH. 2004. 2LD, GENECOUNTING and HAP: Computer programs for linkage disequilibrium analysis. Bioinformatics 20:1325-1326.
37. Zhao JH, Curtis D, Sham PC. 2000. Model-free analysis and permutation tests for allelic associations. Hum Heredity 50:133-139.